120 related articles for article (PubMed ID: 2400937)
1. Ganglioside composition of human melanoma and response to antitumor treatment.
Kono K; Tsuchida T; Kern DH; Irie R
Cancer Invest; 1990; 8(2):161-7. PubMed ID: 2400937
[TBL] [Abstract][Full Text] [Related]
2. Modulation of ganglioside expression in human melanoma cell lines; increased resistance to chemo- and radiation treatment.
Kunitomo K; Irie RF; Kern DH
Tokushima J Exp Med; 1992 Jun; 39(1-2):55-62. PubMed ID: 1384169
[TBL] [Abstract][Full Text] [Related]
3. Gangliosides of human melanoma.
Tsuchida T; Saxton RE; Morton DL; Irie RF
J Natl Cancer Inst; 1987 Jan; 78(1):45-54. PubMed ID: 3467129
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides of human melanoma.
Tsuchida T; Saxton RE; Morton DL; Irie RF
Cancer; 1989 Mar; 63(6):1166-74. PubMed ID: 2917320
[TBL] [Abstract][Full Text] [Related]
5. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells.
Lloyd KO; Gordon CM; Thampoe IJ; DiBenedetto C
Cancer Res; 1992 Sep; 52(18):4948-53. PubMed ID: 1516051
[TBL] [Abstract][Full Text] [Related]
6. Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2.
Hoon DS; Irie RF; Cochran AJ
Cell Immunol; 1988 Feb; 111(2):410-9. PubMed ID: 3123073
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside GD3 shedding by human malignant melanoma cells.
Bernhard H; Meyer zum Büschenfelde KH; Dippold WG
Int J Cancer; 1989 Jul; 44(1):155-60. PubMed ID: 2744885
[TBL] [Abstract][Full Text] [Related]
8. The gangliosides as a possible molecular coupling factor between the proportion of radiosensitive cells in vitro and the metastatic potential in vivo within a human melanoma cell line.
Thomas CP; Buronfosse A; Portoukalian J; Fertil B
Br J Cancer; 1997; 75(5):639-49. PubMed ID: 9043018
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of melanoma-associated gangliosides in cancer patients.
Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
[TBL] [Abstract][Full Text] [Related]
10. GD3 expression by cultured human tumor cells of neuroectodermal origin.
He X; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Acta Neuropathol; 1989; 79(3):317-25. PubMed ID: 2609939
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.
Hamilton WB; Helling F; Lloyd KO; Livingston PO
Int J Cancer; 1993 Feb; 53(4):566-73. PubMed ID: 8436430
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of gangliosides in malignant properties of melanomas.
Ohmi Y; Kambe M; Ohkawa Y; Hamamura K; Tajima O; Takeuchi R; Furukawa K; Furukawa K
PLoS One; 2018; 13(11):e0206881. PubMed ID: 30462668
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside GM3:GD3 ratio as an index for the management of melanoma.
Ravindranath MH; Tsuchida T; Morton DL; Irie RF
Cancer; 1991 Jun; 67(12):3029-35. PubMed ID: 2044049
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and spatial interrelationships between ganglioside glycosyltransferases and O-acetyltransferase(s) in human melanoma cells.
Sjoberg ER; Varki A
J Biol Chem; 1993 May; 268(14):10185-96. PubMed ID: 8486686
[TBL] [Abstract][Full Text] [Related]
15. Characterization of gangliosides in human uveal melanoma cells.
Soulieres D; Rousseau A; Deschenes J; Tremblay M; Tardif M; Pelletier G
Int J Cancer; 1991 Oct; 49(4):498-503. PubMed ID: 1917148
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides of human melanoma: altered expression in vivo and in vitro.
Tsuchida T; Ravindranath MH; Saxton RE; Irie RF
Cancer Res; 1987 Mar; 47(5):1278-81. PubMed ID: 3815339
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells.
Hoon DS; Ando I; Sviland G; Tsuchida T; Okun E; Morton DL; Irie RF
Int J Cancer; 1989 May; 43(5):857-62. PubMed ID: 2714890
[TBL] [Abstract][Full Text] [Related]
18. Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells.
Cheresh DA; Harper JR; Schulz G; Reisfeld RA
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5767-71. PubMed ID: 6385004
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns.
Ruan S; Lloyd KO
Cancer Res; 1992 Oct; 52(20):5725-31. PubMed ID: 1394196
[TBL] [Abstract][Full Text] [Related]
20. Gangliosides of human melanoma: GM2 and tumorigenicity.
Tsuchida T; Saxton RE; Irie RF
J Natl Cancer Inst; 1987 Jan; 78(1):55-60. PubMed ID: 3467130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
